10 Apr 12
Why is Facebook on its way to become a $100 billion dollar enterprise? Because, the corporate world is very comfortable with ‘predictability driven marketing’ surrounded by ‘search based social mediums’ expects ‘click based’ returns on investments and believes in 247/365 multidirectional expansion while rest of the world loves the freedom to engage online.
28 Mar 12
If you want to go further in your clinical research career, the Institute of Clinical Research (ICR) can help. We provide training, analysis and discussion of the issues facing clinical research today, and opportunities for widening your professional network. Join ICR today, and benefit from all these resources straight away, many of them at specially discounted rates.
28 Mar 12
Strontium ranelate (Protelos ®) reduced structural progression of osteoarthritis (OA) in knee joints by one third, finds an international phase III study. The trial, presented at the European Congress of Osteoporosis and Osteoarthritis (IOF-ECCEO) meeting in Bordeaux, France, 21 to 24 March, 2012, is the first study ever to have demonstrated a disease modifying effect in OA, with additional benefits shown for pain, function and mobility.
14 Mar 12
Financial and budgetary, IT and green skills top the list of ten skills that Hays’ global offices and clients commonly identify as being in greatest demand.
“Talent shortages are a global problem,” said Simon Lance, Regional Director of Hays in China. “We operate in 31 countries and these skills are the ones that our clients globally say are in most demand. For anyone considering their career options in our globalised economy, these are the skills to focus on.
Kathy Lou, Marketing Manager of Hays in China
27 Feb 12
This year is another bumper year for employment law changes. In this article we consider the key changes for employers in 2012, planned changes to Employment Tribunal practice and procedure and what changes are still in the pipeline.
16 Feb 12
Suddenly, perfect storms are developing on the global branding fronts; the top of the agenda is now ‘naming’ of the brands itself and how will the names survive the rapid changes of massive digitalization of social media where such name identities reside and skate to catch customers via global cyber branding.
27 Jan 12
The boardroom agendas must raise some of these questions. What are the specific tactical options available for the organization at this stage? What are the hot buttons on name evaluation for national or global cyber name branding? What are the key steps to get current name identity ahead of competitors on fast track basis? What are the new digital platforms for mass-customer-acquisition? What are the methodical steps to market domination via name identity?
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.